Telmisartan Tab Hypertension
NCT00890084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2913
Last updated 2014-04-08
Summary
To assess the efficacy of telmisartan in hypertensive patients with high cardiovascular risk
Conditions
Interventions
- DRUG
-
Telmisartan or Telmisartan + Hydrochlorothiazide (HCTZ)
Telmisartan 40mg or 80mg +/- HCTZ 12.5mg or 25mg
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2009-12-31
More Related Trials
-
Pharmacovigilance and Patient Compliance in Hypertensive Patients
NCT02200575 ·Status: COMPLETED
-
Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II
NCT02262858 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis
NCT02178306 ·Status: COMPLETED ·Phase: PHASE4
-
Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects
NCT02176512 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide
NCT02248129 ·Status: COMPLETED
-
Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers
NCT02262624 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers
NCT02262598 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
NCT00168779 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers
NCT02262780 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers
NCT02276391 ·Status: COMPLETED ·Phase: PHASE1
-
Micardis®. Observational Study in Patients With Essential Hypertension
NCT02200094 ·Status: COMPLETED
-
Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension
NCT02176850 ·Status: COMPLETED
-
A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients
NCT00240448 ·Status: COMPLETED ·Phase: PHASE4
-
Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects
NCT02187523 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension
NCT00890591 ·Status: COMPLETED ·Phase: PHASE4
-
Candesartan Effect in Second Stage Arterial Hypertension
NCT00621153 ·Status: COMPLETED ·Phase: PHASE4
-
The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension
NCT00471003 ·Status: COMPLETED
-
Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
NCT00872586 ·Status: COMPLETED ·Phase: PHASE3
-
Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
NCT00430508 ·Status: COMPLETED ·Phase: PHASE3
-
COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland
NCT01211171 ·Status: COMPLETED
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
NCT00698646 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
NCT02079805 ·Status: COMPLETED ·Phase: PHASE4
-
Olmesartan Medoxomil Versus Losartan in Patients With Hypertension
NCT00857285 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy
NCT01258673 ·Status: COMPLETED ·Phase: PHASE3
-
BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)
NCT00546754 ·Status: COMPLETED ·Phase: PHASE3